Skip to main content
. 2017 Aug 10;56(17):2317–2320. doi: 10.2169/internalmedicine.8488-16

Figure 2.

Figure 2.

(A) Pretreatment optical coherence tomography (OCT) of the right eye during the pre-alectinib screening ophthalmologic examination showing serous retinal detachment and an elevation of the retinal epithelial layer because of the presence of tumor. (B) OCT of the right eye after 2 months of alectinib treatment showing a resolution of the subretinal fluid.